• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

225Ac-DOTATATE therapy in a case of metastatic pheochromocytoma.

作者信息

Peng Dengsai, Liu Hanxiang, Huang Ling, Cao Jianpeng, Chen Yue

机构信息

Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University, No. 25 Taiping St., Jiangyang DistrictSichuan, Luzhou, 646000, People's Republic of China.

Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Sichuan, Luzhou, 646000, People's Republic of China.

出版信息

Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3596-3597. doi: 10.1007/s00259-022-05826-5. Epub 2022 May 6.

DOI:10.1007/s00259-022-05826-5
PMID:35522323
Abstract
摘要

相似文献

1
225Ac-DOTATATE therapy in a case of metastatic pheochromocytoma.225Ac-DOTATATE治疗转移性嗜铬细胞瘤1例
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3596-3597. doi: 10.1007/s00259-022-05826-5. Epub 2022 May 6.
2
177 Lu-DOTATATE in the Treatment of Recurrent Pheochromocytoma With Multiple Metastases.
Clin Nucl Med. 2024 Apr 1;49(4):338-339. doi: 10.1097/RLU.0000000000004994. Epub 2023 Dec 2.
3
Unusual Bone Superscan, MIBG Superscan, and 68Ga DOTATATE PET/CT in Metastatic Pheochromocytoma.罕见的骨骼超级扫描、MIBG 超级扫描和 68Ga DOTATATE PET/CT 在转移性嗜铬细胞瘤中的应用。
Clin Nucl Med. 2015 Nov;40(11):867-8. doi: 10.1097/RLU.0000000000000920.
4
Similar Findings on 18F-MFBG PET/CT and 68Ga-DOTATATE PET/CT in a Patient With Widespread Metastatic Pheochromocytoma.18F-MFBG PET/CT 与 68Ga-DOTATATE PET/CT 在广泛转移嗜铬细胞瘤患者中的相似发现。
Clin Nucl Med. 2022 May 1;47(5):451-453. doi: 10.1097/RLU.0000000000003997.
5
Subclinical Hypothyroidism After 225Ac-DOTATATE Therapy in a Case of Metastatic Neuroendocrine Tumor: Unknown Adverse Effect of PRRT.225Ac-DOTATATE 治疗转移性神经内分泌肿瘤后发生亚临床甲状腺功能减退症：PRRT 的未知不良反应。
Clin Nucl Med. 2022 Feb 1;47(2):e184-e186. doi: 10.1097/RLU.0000000000003893.
6
Malignant pheochromocytoma and paraganglioma: three cases illustrating the use of molecular targeted diagnostics and therapy and possible role of new drugs.恶性嗜铬细胞瘤和副神经节瘤：三例病例说明分子靶向诊断与治疗的应用及新药的可能作用
Acta Oncol. 2011 Nov;50(8):1255-9. doi: 10.3109/0284186X.2011.584552. Epub 2011 Jun 30.
7
Alpha Before Beta: Exceptional Response to First-Line 225Ac-DOTATATE in a Patient of Metastatic Neuroendocrine Tumor With Extensive Skeletal Involvement.阿尔法先于贝塔：广泛骨骼累及的转移性神经内分泌肿瘤患者一线接受 225Ac-DOTATATE 治疗后出现显著疗效。
Clin Nucl Med. 2022 Feb 1;47(2):e156-e157. doi: 10.1097/RLU.0000000000003823.
8
Hypertensive crisis due to contrast-enhanced computed tomography in a patient with malignant pheochromocytoma.恶性嗜铬细胞瘤患者行增强 CT 检查后发生高血压危象。
Jpn J Radiol. 2011 Jul;29(6):449-51. doi: 10.1007/s11604-011-0573-y. Epub 2011 Jul 24.
9
Ga-DOTATATE PET and functional imaging in pediatric pheochromocytoma and paraganglioma.镓-DOTATATE PET 与儿童嗜铬细胞瘤和副神经节瘤的功能成像。
Pediatr Blood Cancer. 2022 Aug;69(8):e29740. doi: 10.1002/pbc.29740. Epub 2022 Apr 29.
10
Concurrent Metastatic Pheochromocytomas and Lung Adenocarcinoma on 18F-FDG and 68Ga-DOTATATE PET/CT Images.18F-FDG 和 68Ga-DOTATATE PET/CT 图像上同时出现的嗜铬细胞瘤和肺腺癌转移。
Clin Nucl Med. 2019 Sep;44(9):754-756. doi: 10.1097/RLU.0000000000002588.

引用本文的文献

1
Peptide receptor radionuclide therapy in advanced Pheochromocytomas and Paragangliomas: a systematic review and meta-analysis.晚期嗜铬细胞瘤和副神经节瘤的肽受体放射性核素治疗：一项系统评价和荟萃分析。
Front Oncol. 2023 Jul 6;13:1141648. doi: 10.3389/fonc.2023.1141648. eCollection 2023.
2
Ac-Labeled Somatostatin Analogs in the Management of Neuroendocrine Tumors: From Radiochemistry to Clinic.用于神经内分泌肿瘤治疗的锕标记生长抑素类似物：从放射化学到临床应用
Pharmaceutics. 2023 Mar 24;15(4):1051. doi: 10.3390/pharmaceutics15041051.

本文引用的文献

1
Broadening horizons with Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety.用Ac-DOTATATE靶向α治疗拓宽胃肠胰神经内分泌肿瘤患者的视野，这些患者对Lu-DOTATATE肽受体放射性核素治疗稳定或难治：疗效和安全性的首次临床经验
Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):934-946. doi: 10.1007/s00259-019-04567-2. Epub 2019 Nov 10.
2
Neuroendocrine Tumor Therapy: Lu-DOTATATE.神经内分泌肿瘤治疗：镥[177Lu]-DOTATATE。
AJR Am J Roentgenol. 2018 Aug;211(2):278-285. doi: 10.2214/AJR.18.19953. Epub 2018 Jun 27.
3
Phase 3 Trial of Lu-Dotatate for Midgut Neuroendocrine Tumors.
镥[177Lu]奥曲肽治疗中肠神经内分泌肿瘤的3期试验
N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427.
4
Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate.用新型放射性标记的生长抑素类似物[177Lu-DOTA(0),Tyr3]奥曲肽治疗胃肠胰（GEP）肿瘤患者。
Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):417-22. doi: 10.1007/s00259-002-1050-8. Epub 2003 Jan 9.
5
Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine.恶性嗜铬细胞瘤：环磷酰胺、长春新碱和达卡巴嗪联合治疗有效
Ann Intern Med. 1988 Aug 15;109(4):267-73. doi: 10.7326/0003-4819-109-4-267.